Bausch Health Companies Inc. (BHC)
Sector: Healthcare
Industry: Pharmaceutical Preparations
Country: Canada
Exchange: NYSE
Market cap: $2.96B
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Latest financial period: June 30, 2026
Filed with the SEC: July 30, 2026
Estimated earnings date: November 4, 2026
Profit #1125 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | 4.3% | 3.4% | 5.8% | 6.0% |
Growth #613 of 1484 companies
Payout #1117 of 1484 companies
Safety #1029 of 1484 companies
Price #730 of 1484 companies
